Blog | Celligenics 2023

Celligenics Publishes Latest Scientific Paper On Springer Nature

Celligenics is proud to announce the publication of our latest scientific breakthrough: "Development and functional testing of a novel in...

Celligenics Announces China Market Entry, & Signs MOU With West China Hospital

Celligenics is pleased to announce that we have signed a memorandum of understanding with West China Hospital (Hua Xi) of Sichuan...

Celligenics, NTU, & SRIS Collaborate On New Therapy For Chronic Wounds (Sep 2021)

Celligenics is pleased to announce that we have signed a research collaboration agreement with local research institutes, Nanyang...

Celligenics Unveils Corporate Video Titled Enabling Cellular Therapeutics (May 2021)

Celligenics is pleased to unveil its first corporate video, titled Enabling Cellular Therapeutics. The video introduces our research team...

Celligenics Signs MOU With Series A Investor Best World International (April 2021)

Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World...

Celligenics & SRIS Visit Changi General Hospital's Wound Care Clinic (Mar 2020)

Celligenics visited Changi General Hospital (CGH)'s Wound Care Clinic with the Skin Research Institute of Singapore (SRIS) yesterday, and...

Celligenics Participates In Biotech Dialogue Session With MTI 2M Dr. Tan See Leng (Feb 2020)

Celligenics is honoured to have participated in a dialogue session comprising industry representatives from local biotech, venture...

Celligenics Participates In SWITCH For Third Consecutive Year (Dec 2020)

Celligenics is proud to announce that we will be participating in the Singapore Week of Innovation and Technology (SWITCH) for our third...

Celligenics Participates In SWITCH For Second Consecutive Year (Nov 2019)

Celligenics is proud to have participated in the Singapore Week of Innovation and Technology (SWITCH) for our second consecutive year....

Celligenics Appoints Dr. Pauline Tay As Chief Operating Officer (Sep 2019)

Celligenics is pleased to announce the appointment of Dr. Pauline Tay as Chief Operating Officer. Dr. Tay joins us from the National...

Celligenics Raises S$5.6 Mio For Series A With Best World International (Jan 2019)

Celligenics is pleased to announce the close of our Series A fundraising exercise, raising $5.6 Mio, with Best World International (BWI)...

Subscribe